Skip to content

fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease

fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00478491
Acronym
ALZ
Enrollment
390
Registered
2007-05-24
Start date
2003-01-31
Completion date
2011-07-31
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Children, Alzheimer's Disease, Dementia, Magnetic Resonance Imaging, Risk

Brief summary

The purpose of this study is to investigate the organization of memory and develop future methods for early detection of AD. Using functional magnetic resonance imaging (fMRI), we examine the responsiveness of the brain to memory tasks, specifically focusing on regions of the brain (the mesial temporal lobe and posterior cingulate) that are known to be involved in early stages of Alzheimer's disease (AD). Of interest are differences in brain activation between people with and without a family history of AD and other risk factors.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Aging (NIA)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* MCI Group: Diagnosis of mild cognitive impairment * AD Family History Group: Confirmed family history of Alzheimer's and concurrent enrollment in the Wisconsin Registry for Alzheimer's Prevention (WRAP) * Control Groups: Cognitively healthy and both parents survived past age 70 with no memory problems

Exclusion criteria

* Claustrophobia * Metallic or electronic implants or devices that are not MRI-safe

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026